Tag: Research
-
New Version of COVID-19 Vaccine Controls Breakthrough Infections Better
A new combination COVID-19 vaccine improved protection against breakthrough infections in mice, according to a recent Northwestern Medicine study.
-
Strengthened Microtubules Aid Cell Migration
Migrating cells use stiffened microtubules to push through tissue barriers, seeking out weak points in tissue, according to a recent study.
-
Uncovering Molecular Mechanisms Behind Cell Signaling
A study led by Northwestern Medicine investigators has identified the molecular mechanisms within protein complexes that promote cell-to-cell adhesion and communication.
-
Neurons That Respond to Touch are Less Picky Than Expected
Touch-sensitive neurons responded to many types of touch and to varying degrees – in a much messier and jumbled manner than previous predicted, according to a recent study.
-
Hypoxic Inflammation Blunts Repair After Heart Attack
Inefficient cardiac repair after heart attacks is partially driven by a maladapted response to a low oxygen environment by immune cells, according to a study published in the Journal of Experimental Medicine.
-
Study Identifies Genetic Variants Associated with COVID-19 Severity
In collaboration with Northwestern Medicine investigators, an international multi-center study has identified genetic factors associated with SARS-CoV-2 infection and COVID-19 severity.
-
Gene Implicated in Poor Skin Cancer Therapy Outcomes
Losing a check on T-cell activation in cutaneous T-cell lymphoma cells is associated with poor outcomes, according to a study published in Blood.
-
Using Circulating Tumor DNA to Target Immunotherapy
Using circulating tumor DNA to identify patients at risk for urothelial cancer relapse after surgical resection could help improve post-surgery treatment, according to a new study.
-
Nanoparticles Could Boost Immunotherapy
Enhancing the anti-cancer function of natural killer cells with nanoparticles could unlock their therapeutic potential, according to a Northwestern Medicine study.
-
Combined Therapy Shows Promise for Chronic Lymphocytic Leukemia
A combination therapy pairing a small molecule inhibitor with monoclonal antibody immunotherapy improved patient outcomes for relapsed chronic lymphocytic leukemia, according to a Northwestern Medicine clinical trial.
